Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Kadmon Corp LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013479
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phentermine and topiramate extended-release capsules and trientine hydrochloride. Kadmon offers products in the therapeutic areas of oncology, infectious diseases, immunology, and neurodegenerative disease. The company’s discovery platforms include metabolomics, chromics, monoclonal antibodies, synthetic biology and gene regulation. It undertakes identification and evaluation of investigational compounds, which show the potential to improve patient outcomes. Kadmon is headquartered in New York, the US.

Kadmon Corp LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kadmon Corp LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Kadmon Acquires Rights To Salirasib From Concordia Pharma 12
Venture Financing 13
Kadmon Raises USD5.7 Million in Venture Financing 13
Kadmon Raises US$4.7 Million In Venture Financing 14
Kadmon Pharma Secures US$40 Million In Venture Financing 15
Partnerships 16
Kadmon Amends Distribution Agreement with Camber Pharma 16
Kadmon Enters into R&D Agreement with NIDCR 17
EffRx Pharma Enters An Agreement With Kadmon 18
Kadmon Pharma Enters Into Co-Promotion Agreement With Valeant Pharma For Syprine Capsules 19
Kadmon Pharma Forms Joint Venture With Nano Terra 20
Licensing Agreements 22
Nantong Jinghua Pharma Enters into Licensing Agreement with Kadmon 22
Kadmon Enters into Licensing Agreement with VIVUS for Qsymia 23
AbbVie Enters into Licensing Agreement with Kadmon for Ribasphere 24
Dyax Enters Into Licensing Agreement With Kadmon For Oncology Drug 25
Kadmon Enters Into Licensing Agreement With Chiromics For Chemical Compounds Library 27
Dyax Enters Into Licensing Agreement With Kadmon 28
Equity Offering 29
Kadmon Plans to Raise USD40 Million in Public Offering of Shares 29
Kadmon Plans to Raise Funds through Public Offering of Shares 30
Kadmon Prices IPO for USD75 Million 31
Kadmon Raises USD11 Million in Private Placement of Units 33
Kadmon Raises USD5.5 Million in Private Placement of Units 34
Kadmon Raises USD10 Million in Private Placement of Units 35
Kadmon Raises USD35 Million in Private Placement of Units 36
Kadmon Raises USD15 Million in Private Placement of Units 37
Asset Transactions 38
AbbVie Acquires Rights to Ribasphere from Kadmon 38
Acquisition 39
MeiraGTx Acquires Kadmon Gene Therapy from Kadmon 39
Kadmon Corp LLC – Key Competitors 40
Kadmon Corp LLC – Key Employees 41
Kadmon Corp LLC – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
Sep 07, 2016: Kadmon Reports Financial and Operational Results for the Three and Six Months Ended June 30, 2016 43
Clinical Trials 44
Apr 14, 2016: Kadmon to Present Preclinical Data Demonstrating that its Novel Immuno-Oncology Compound Achieves Long-Lasting and Persistent Antitumor Immunity 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Key Facts 2
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kadmon Corp LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kadmon Corp LLC, Deals By Therapy Area, 2011 to YTD 2017 9
Kadmon Corp LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kadmon Acquires Rights To Salirasib From Concordia Pharma 12
Kadmon Raises USD5.7 Million in Venture Financing 13
Kadmon Raises US$4.7 Million In Venture Financing 14
Kadmon Pharma Secures US$40 Million In Venture Financing 15
Kadmon Amends Distribution Agreement with Camber Pharma 16
Kadmon Enters into R&D Agreement with NIDCR 17
EffRx Pharma Enters An Agreement With Kadmon 18
Kadmon Pharma Enters Into Co-Promotion Agreement With Valeant Pharma For Syprine Capsules 19
Kadmon Pharma Forms Joint Venture With Nano Terra 20
Nantong Jinghua Pharma Enters into Licensing Agreement with Kadmon 22
Kadmon Enters into Licensing Agreement with VIVUS for Qsymia 23
AbbVie Enters into Licensing Agreement with Kadmon for Ribasphere 24
Dyax Enters Into Licensing Agreement With Kadmon For Oncology Drug 25
Kadmon Enters Into Licensing Agreement With Chiromics For Chemical Compounds Library 27
Dyax Enters Into Licensing Agreement With Kadmon 28
Kadmon Plans to Raise USD40 Million in Public Offering of Shares 29
Kadmon Plans to Raise Funds through Public Offering of Shares 30
Kadmon Prices IPO for USD75 Million 31
Kadmon Raises USD11 Million in Private Placement of Units 33
Kadmon Raises USD5.5 Million in Private Placement of Units 34
Kadmon Raises USD10 Million in Private Placement of Units 35
Kadmon Raises USD35 Million in Private Placement of Units 36
Kadmon Raises USD15 Million in Private Placement of Units 37
AbbVie Acquires Rights to Ribasphere from Kadmon 38
MeiraGTx Acquires Kadmon Gene Therapy from Kadmon 39
Kadmon Corp LLC, Key Competitors 40
Kadmon Corp LLC, Key Employees 41
Kadmon Corp LLC, Other Locations 42
Kadmon Corp LLC, Subsidiaries 42

★海外企業調査レポート[Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rafael Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), a subsidiary of IDT Corp is a healthcare products provider that offers therapeutics. The company develops drug therapies for the treatment of cancer. It provides altered energy metabolism directed platform for cancer cell energy metabolism …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Naftna industrija Srbije ad (NIIS):企業の財務・戦略的SWOT分析
    Naftna industrija Srbije ad (NIIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Aeon Global Health Corp (ADAT):医療機器:M&Aディール及び事業提携情報
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp, is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory service …
  • Onorach Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Onorach Ltd (Onorach) is a contract research organization that provides clinical support services. The organization service portfolio includes tailored clinical trial support, clinical plan development, protocol design, regulatory, quality management, clinical operations management, patient …
  • International Coffee & Tea, LLC:戦略・SWOT・企業財務分析
    International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report Summary International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ashoka Buildcon Ltd (ASHOKA):企業の財務・戦略的SWOT分析
    Ashoka Buildcon Ltd (ASHOKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ferrellgas Partners LP (FGP):企業の財務・戦略的SWOT分析
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …
  • Electricity Generating Authority of Thailand:企業の発電所・SWOT分析2018
    Electricity Generating Authority of Thailand - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Hamburg Commercial Bank
    Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Biglari Holdings Inc.:企業の戦略・SWOT・財務情報
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Ra Pharmaceuticals Inc (RARX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that conducts research on stem cell and regenerative medicine, chemical biology, infection and immunity, public health and scientific research equipment development. The institute’s life process and disease mechanis …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • Cryogenmash:企業の戦略的SWOT分析
    Cryogenmash - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GeeCee Ventures Ltd (GEECEE):企業の財務・戦略的SWOT分析
    GeeCee Ventures Ltd (GEECEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務情報
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆